An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus
- PMID: 20340033
- PMCID: PMC3015200
- DOI: 10.1007/s00432-010-0868-x
An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus
Abstract
Purpose: Many physicians express a relatively nihilistic approach to the treatment of hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). Consensus among surgeons regarding the indications for an aggressive approach has not been reached. Current study was aimed to determine whether an aggressive approach, with an extended resection with thrombectomy and adjuvant therapy, would lead to an improved survival for HCC patients with PVTT.
Methods: A retrospective review of 116 HCC patients with PVTT admitted from 1996 to 2006 was conducted. Patients were divided into 2 time-period (TP) cohorts, of them, 51 cases in the first 5 years (TP1) and 65 in the last 5 years (TP2).
Results: Surgical operations were performed on 68 patients. Twenty-one surgical resections were performed in TP1 and forty-seven in TP2. The extent of liver resections, as well as the frequency of thrombectomy, was greater in TP2 (P = 0.039). During both time-periods, an aggressive therapy was associated with improved survival (P < 0.02 TP1, P < 0.001 TP2). Overall survival of all patients in TP2 was significantly greater than in TP1 (P < 0.001), with a median survival of 15 months in TP2, whereas in TP1, the survival was only 9 months. The median 1-, 3-year survivals in TP2 (54 and 34%, respectively) were also greater than that in TP1 (31 and 7%, respectively). A multiple logistic regression analysis revealed that radical resection and adjuvant therapy were the independent predictors of overall survival.
Conclusions: An aggressive approach, combining extended liver resection with thrombectomy and adjuvant therapy, leads to an improved survival in the HCC patients with PVTT.
Figures




Similar articles
-
Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma.Ann Surg Oncol. 2006 Jul;13(7):940-6. doi: 10.1245/ASO.2006.08.007. Epub 2006 May 23. Ann Surg Oncol. 2006. PMID: 16788755
-
Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.Ann Surg Oncol. 2010 Aug;17(8):2073-80. doi: 10.1245/s10434-010-0940-4. Epub 2010 Feb 4. Ann Surg Oncol. 2010. PMID: 20131013
-
New macroscopic classification and back-flow thrombectomy for advanced hepatocellular carcinoma with portal vein tumor thrombus invading the contralateral second portal branch.Surg Today. 2017 Sep;47(9):1094-1103. doi: 10.1007/s00595-017-1507-9. Epub 2017 Mar 21. Surg Today. 2017. PMID: 28324163
-
Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus.World J Gastroenterol. 2018 Oct 28;24(40):4527-4535. doi: 10.3748/wjg.v24.i40.4527. World J Gastroenterol. 2018. PMID: 30386102 Free PMC article. Review.
-
A systematic review comparing outcomes of surgical resection and non-surgical treatments for patients with hepatocellular carcinoma and portal vein tumor thrombus.HPB (Oxford). 2018 Dec;20(12):1119-1129. doi: 10.1016/j.hpb.2018.06.1804. Epub 2018 Jul 25. HPB (Oxford). 2018. PMID: 30056066
Cited by
-
Comparison of treatments for hepatocellular carcinoma patients with portal vein thrombosis: a systematic review and network meta-analysis.Ann Transl Med. 2021 Sep;9(18):1450. doi: 10.21037/atm-21-3937. Ann Transl Med. 2021. PMID: 34734002 Free PMC article.
-
Radiotherapeutic options for hepatocellular carcinoma with portal vein tumor thrombosis.Liver Cancer. 2014 Mar;3(1):18-30. doi: 10.1159/000343855. Liver Cancer. 2014. PMID: 24804174 Free PMC article. Review.
-
Management of hepatocellular carcinoma with portal vein thrombosis.World J Gastroenterol. 2015 Mar 28;21(12):3462-71. doi: 10.3748/wjg.v21.i12.3462. World J Gastroenterol. 2015. PMID: 25834310 Free PMC article. Review.
-
Anatomical liver segmentectomy 2 for combined hepatocellular carcinoma and cholangiocarcinoma with tumor thrombus in segment 2 portal branch.World J Surg Oncol. 2012 Jan 25;10:22. doi: 10.1186/1477-7819-10-22. World J Surg Oncol. 2012. PMID: 22273493 Free PMC article.
-
Serum miR-224 reflects stage of hepatocellular carcinoma and predicts survival.Biomed Res Int. 2015;2015:731781. doi: 10.1155/2015/731781. Epub 2015 Jan 22. Biomed Res Int. 2015. PMID: 25688365 Free PMC article.
References
-
- Aldrighetti L, Pulitano C, Catena M, Arru M, Guzzetti E, Halliday J, Ferla G (2009) Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion. Ann Surg Oncol 16(5):1254. doi:10.1245/s10434-009-0383-y - PubMed
-
- Bruix J, Llovet JM (2002) Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35(3):519–524. doi:10.1053/jhep.2002.32089 - PubMed
-
- Chen XP, Qiu FZ, Wu ZD, Zhang ZW, Huang ZY, Chen YF, Zhang BX, He SQ, Zhang WG (2006) Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma. Ann Surg Oncol 13(7):940–946. doi:10.1245/ASO.2006.08.007 - PubMed
-
- Chung JW, Park JH, Han JK, Choi BI, Han MC (1995) Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. AJR Am J Roentgenol 165(2):315–321 - PubMed
-
- Couinaud C (1994) Intrahepatic anatomy. Application to liver transplantation. Ann Radiol (Paris) 37(5):323–333 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical